Standout Papers

Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 c... 2007 2026 2013 2019 780
  1. Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial (2007)
    Lu Zhang, Ferenc Martényi et al. Nature Medicine

Immediate Impact

4 by Nobel laureates 20 from Science/Nature 60 standout
Sub-graph 1 of 20

Citing Papers

Theranostic Fluorescent Probes
2024 Standout
Psychedelics promote neuroplasticity through the activation of intracellular 5-HT2A receptors
2023 StandoutScience
3 intermediate papers

Works of Smulevich Ab being referenced

Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial
2007 Standout

Author Peers

Author Last Decade Papers Cites
Smulevich Ab 493 94 125 593 425 72 1.2k
Morozova Ma 604 107 129 708 545 60 1.5k
Н. Г. Незнанов 315 36 119 675 489 106 1.4k
Giovanni Muscettola 544 41 157 524 339 62 1.7k
Ken Yamauchi 311 82 121 236 307 45 1.1k
Anne‐Noël Samaha 443 63 153 873 387 42 1.4k
А С Аведисова 250 28 110 593 418 39 1.0k
H. Lôo 642 84 161 402 205 65 1.3k
Enrico Lattuada 831 63 223 567 281 44 1.6k
L. Bjerkenstedt 708 41 107 455 353 50 1.4k
Maria Rogdaki 643 62 165 446 427 49 1.6k

All Works

Loading papers...

Rankless by CCL
2026